Efficacy of Manuka Honey Nano-Formulation in the Treatment of Acne Vulgaris

Launched by AL-AZHAR UNIVERSITY · Dec 8, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment for acne vulgaris, which is a common skin condition that causes pimples and breakouts. Researchers are testing a special formulation of Manuka honey, which is known for its healing properties, to see if it can help reduce the severity and frequency of acne compared to standard acne treatments. The goal is to find a more effective option for people dealing with this skin issue.

To participate in the study, individuals must be between 18 and 40 years old and have mild to moderate acne. Unfortunately, those who are pregnant, have severe acne, or have certain skin conditions or serious health issues will not be eligible. If you qualify and choose to participate, you can expect to use the Manuka honey treatment over a period of time while being monitored for its effects on your acne. The trial is not yet recruiting participants, but it aims to offer new insights into acne treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Mild to moderate acne vulgaris patients.Patients will be assessed for severity of acne by Global acne grading system (GAGS).
• • Age of patients: 18-40 years.
• • Sex: both sexes.
• Exclusion Criteria:
• • Pregnancy and lactation.
• • severe acne vulgaris.
• • exogenous acne as industrial or cosmetic causes.
• • Patients with photodermatitis or allergic dermatitis.
• • serious or systemic illnesses such as liver and renal dysfunction.
• • Patients with radiotherapy, cryotherapy, cutaneous malignant tumors, and patients suffer from mental illnesses.